Pneumagen Ltd
4Patents
4Active
4Granted
43Portfolio score
Filing activity: Sep 20, 2017 → Feb 27, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11466059B2 | Modified protein | Emerging Cross-Sectional Technologies | 1 | Active |
| US10953078B2 | Treatment and/or prevention of sepsis | Physics | 0 | Active |
| US11406704B2 | Adjuvants | Chemistry; Metallurgy | 0 | Active |
| US11819534B2 | Viral treatment | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.